Echocardiography-based left ventricular mass estimation. How should we define hypertrophy?

Murilo Foppa1, Bruce B Duncan, Luis E P Rohde

  • 1Graduate Studies Program in Cardiology, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre-RS, Brazil. mfoppa@cpovo.net

Insights

Left ventricular hypertrophy is a key cardiovascular disease risk factor. Echocardiography remains a valuable diagnostic tool, despite variability in older study methods, for assessing left ventricular structure.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular disease.
  • Echocardiography is a primary diagnostic method for LVH.

Purpose of the Study:

  • To review common left ventricular hypertrophy evaluation measures.
  • To assess echocardiography's role in diagnosing left ventricular structure changes.
  • To highlight echocardiography's continued accuracy and cost-effectiveness.

Main Methods:

  • Review of common echocardiographic measures for LVH.
  • Analysis of recent population-based echocardiographic studies.
  • Evaluation of measurement and data interpretation variability in older studies.

Main Results:

  • Older echocardiographic studies exhibit variability in measurement and interpretation criteria.
  • Differences in LV mass formulas and body size indexing affect study comparability.
  • Echocardiography demonstrates consistent accuracy in LVH assessment.

Conclusions:

  • Despite historical variability, echocardiography remains a cost-effective and accurate tool for diagnosing left ventricular hypertrophy.
  • Standardization of methods is crucial for reliable clinical and epidemiologic use of echocardiography.
  • Echocardiography continues to be essential for investigating left ventricular structure.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...